Loading…

Investigation Into Some Aspects of EMIT d.a.u., TLC, and GC-MS Urinalysis of Bromazepam

Among the different 1,4-benzodiazepine urinary metabolites, those of bromazepam possess distinctive chemical features that may be used in their selective isolation and detection. The detection of bromazepam metabolites in urine was carried out using EMIT d.a.u., thin-layer chromatography (TLC), and...

Full description

Saved in:
Bibliographic Details
Published in:Journal of analytical toxicology 2001-07, Vol.25 (5), p.316-322
Main Authors: El-Haj, B.M., Al-Amri, A.M., Hassan, M.H., Bin-Khadem, R.K.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c424t-6286a1bd67d1729bdb7d26e1e1f5be4658786d8ff012052decaf3dcc9ac02eb93
cites
container_end_page 322
container_issue 5
container_start_page 316
container_title Journal of analytical toxicology
container_volume 25
creator El-Haj, B.M.
Al-Amri, A.M.
Hassan, M.H.
Bin-Khadem, R.K.
description Among the different 1,4-benzodiazepine urinary metabolites, those of bromazepam possess distinctive chemical features that may be used in their selective isolation and detection. The detection of bromazepam metabolites in urine was carried out using EMIT d.a.u., thin-layer chromatography (TLC), and gas chromatography-mass spectrometry (GC-MS). The positive EMIT d.a.u. benzodiazepine assay for bromazepam was found to be due to the 3-hydroxybromazepam (3HOB) metabolite. The detection by TLC and GC-MS was carried out after enzyme or acid hydrolysis of the glucuronide conjugates. Both the 2-amino-3-hydroxy-5-bromobenzoylpyridine (AHBBP) metabolite and the acid hydrolysis product of 3-HOB, 2-amino-5-bromobenzoylpyridine (ABBP), were selectively detected by TLC. The bromazepam metabolites in urine could be both isolated and detected selectively by GC-MS in the presence of the metabolites of other 1,4-benzodiazepines that were sometimes used in combination with bromazepam. Both 3-HOB and AHBBP were detected by GC-MS only after trimethylsilyl (TMS) derivatization and not as the free compounds or the acetyl derivatives. Only ABBP was detected in three forms: ABBP, the TMS derivative, and the acetyl derivative. Evidence has been obtained from the enzyme hydrolysis and the TLC studies for the formation of the glucuronide conjugate of AHBBP at the 3-OH group rather than at the 2-NH2 group. All the results have been validated using reference 3-HOB and AHBBP.
doi_str_mv 10.1093/jat/25.5.316
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18248039</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/jat/25.5.316</oup_id><sourcerecordid>18248039</sourcerecordid><originalsourceid>FETCH-LOGICAL-c424t-6286a1bd67d1729bdb7d26e1e1f5be4658786d8ff012052decaf3dcc9ac02eb93</originalsourceid><addsrcrecordid>eNqF0M9P2zAYx2ELbRod223nyYeJXZrg33GOUDGo1IpDS4e4WI7toEASBzuZxv56UloNbpx8efR95Q8A3zBKMcrpyb3uTwhPeUqxOAATnDOeEIboBzBBmImEZQIdgs8x3iOEhRT0EzjEmOW5lGwCfs_bPy721Z3uK9_Cedt7uPKNg6exc6aP0JfwfDlfQ5vqdEincL2YTaFuLbyYJcsVvA5Vq-unWL3Is-Ab_c91uvkCPpa6ju7r_j0C17_O17PLZHF1MZ-dLhLDCOsTQaTQuLAiszgjeWGLzBLhsMMlLxwTXGZSWFmWCBPEiXVGl9Qak2uDiCtyegSOd7td8I_D-BPVVNG4utat80NUWBImEd3C6Q6a4GMMrlRdqBodnhRGahtSjSEV4YqrMeTIv-93h6Jx9hXvy43gxx7oaHRdBt2aKr4ZlSzPtuznjvmhe-9ispNV7N3f_1aHByUymnF1eXOr1nyzWcqbldrQZ3i2lYM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18248039</pqid></control><display><type>article</type><title>Investigation Into Some Aspects of EMIT d.a.u., TLC, and GC-MS Urinalysis of Bromazepam</title><source>Oxford Journals Online</source><source>Alma/SFX Local Collection</source><creator>El-Haj, B.M. ; Al-Amri, A.M. ; Hassan, M.H. ; Bin-Khadem, R.K.</creator><creatorcontrib>El-Haj, B.M. ; Al-Amri, A.M. ; Hassan, M.H. ; Bin-Khadem, R.K.</creatorcontrib><description>Among the different 1,4-benzodiazepine urinary metabolites, those of bromazepam possess distinctive chemical features that may be used in their selective isolation and detection. The detection of bromazepam metabolites in urine was carried out using EMIT d.a.u., thin-layer chromatography (TLC), and gas chromatography-mass spectrometry (GC-MS). The positive EMIT d.a.u. benzodiazepine assay for bromazepam was found to be due to the 3-hydroxybromazepam (3HOB) metabolite. The detection by TLC and GC-MS was carried out after enzyme or acid hydrolysis of the glucuronide conjugates. Both the 2-amino-3-hydroxy-5-bromobenzoylpyridine (AHBBP) metabolite and the acid hydrolysis product of 3-HOB, 2-amino-5-bromobenzoylpyridine (ABBP), were selectively detected by TLC. The bromazepam metabolites in urine could be both isolated and detected selectively by GC-MS in the presence of the metabolites of other 1,4-benzodiazepines that were sometimes used in combination with bromazepam. Both 3-HOB and AHBBP were detected by GC-MS only after trimethylsilyl (TMS) derivatization and not as the free compounds or the acetyl derivatives. Only ABBP was detected in three forms: ABBP, the TMS derivative, and the acetyl derivative. Evidence has been obtained from the enzyme hydrolysis and the TLC studies for the formation of the glucuronide conjugate of AHBBP at the 3-OH group rather than at the 2-NH2 group. All the results have been validated using reference 3-HOB and AHBBP.</description><identifier>ISSN: 0146-4760</identifier><identifier>EISSN: 1945-2403</identifier><identifier>DOI: 10.1093/jat/25.5.316</identifier><identifier>PMID: 11499884</identifier><identifier>CODEN: JATOD3</identifier><language>eng</language><publisher>Niles, IL: Oxford University Press</publisher><subject>Analysis ; Biological and medical sciences ; bromazepam ; Bromazepam - analogs &amp; derivatives ; Bromazepam - analysis ; Bromazepam - metabolism ; Bromazepam - urine ; Chromatography, Thin Layer ; Enzyme Multiplied Immunoassay Technique ; Gas Chromatography-Mass Spectrometry ; General pharmacology ; Humans ; Medical sciences ; Pharmacology. Drug treatments ; Substance Abuse Detection - methods</subject><ispartof>Journal of analytical toxicology, 2001-07, Vol.25 (5), p.316-322</ispartof><rights>2001</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c424t-6286a1bd67d1729bdb7d26e1e1f5be4658786d8ff012052decaf3dcc9ac02eb93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,777,781,786,787,23911,23912,25121,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1084974$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11499884$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>El-Haj, B.M.</creatorcontrib><creatorcontrib>Al-Amri, A.M.</creatorcontrib><creatorcontrib>Hassan, M.H.</creatorcontrib><creatorcontrib>Bin-Khadem, R.K.</creatorcontrib><title>Investigation Into Some Aspects of EMIT d.a.u., TLC, and GC-MS Urinalysis of Bromazepam</title><title>Journal of analytical toxicology</title><addtitle>Journal of Analytical Toxicology</addtitle><addtitle>Journal of Analytical Toxicology</addtitle><description>Among the different 1,4-benzodiazepine urinary metabolites, those of bromazepam possess distinctive chemical features that may be used in their selective isolation and detection. The detection of bromazepam metabolites in urine was carried out using EMIT d.a.u., thin-layer chromatography (TLC), and gas chromatography-mass spectrometry (GC-MS). The positive EMIT d.a.u. benzodiazepine assay for bromazepam was found to be due to the 3-hydroxybromazepam (3HOB) metabolite. The detection by TLC and GC-MS was carried out after enzyme or acid hydrolysis of the glucuronide conjugates. Both the 2-amino-3-hydroxy-5-bromobenzoylpyridine (AHBBP) metabolite and the acid hydrolysis product of 3-HOB, 2-amino-5-bromobenzoylpyridine (ABBP), were selectively detected by TLC. The bromazepam metabolites in urine could be both isolated and detected selectively by GC-MS in the presence of the metabolites of other 1,4-benzodiazepines that were sometimes used in combination with bromazepam. Both 3-HOB and AHBBP were detected by GC-MS only after trimethylsilyl (TMS) derivatization and not as the free compounds or the acetyl derivatives. Only ABBP was detected in three forms: ABBP, the TMS derivative, and the acetyl derivative. Evidence has been obtained from the enzyme hydrolysis and the TLC studies for the formation of the glucuronide conjugate of AHBBP at the 3-OH group rather than at the 2-NH2 group. All the results have been validated using reference 3-HOB and AHBBP.</description><subject>Analysis</subject><subject>Biological and medical sciences</subject><subject>bromazepam</subject><subject>Bromazepam - analogs &amp; derivatives</subject><subject>Bromazepam - analysis</subject><subject>Bromazepam - metabolism</subject><subject>Bromazepam - urine</subject><subject>Chromatography, Thin Layer</subject><subject>Enzyme Multiplied Immunoassay Technique</subject><subject>Gas Chromatography-Mass Spectrometry</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Substance Abuse Detection - methods</subject><issn>0146-4760</issn><issn>1945-2403</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqF0M9P2zAYx2ELbRod223nyYeJXZrg33GOUDGo1IpDS4e4WI7toEASBzuZxv56UloNbpx8efR95Q8A3zBKMcrpyb3uTwhPeUqxOAATnDOeEIboBzBBmImEZQIdgs8x3iOEhRT0EzjEmOW5lGwCfs_bPy721Z3uK9_Cedt7uPKNg6exc6aP0JfwfDlfQ5vqdEincL2YTaFuLbyYJcsVvA5Vq-unWL3Is-Ab_c91uvkCPpa6ju7r_j0C17_O17PLZHF1MZ-dLhLDCOsTQaTQuLAiszgjeWGLzBLhsMMlLxwTXGZSWFmWCBPEiXVGl9Qak2uDiCtyegSOd7td8I_D-BPVVNG4utat80NUWBImEd3C6Q6a4GMMrlRdqBodnhRGahtSjSEV4YqrMeTIv-93h6Jx9hXvy43gxx7oaHRdBt2aKr4ZlSzPtuznjvmhe-9ispNV7N3f_1aHByUymnF1eXOr1nyzWcqbldrQZ3i2lYM</recordid><startdate>20010701</startdate><enddate>20010701</enddate><creator>El-Haj, B.M.</creator><creator>Al-Amri, A.M.</creator><creator>Hassan, M.H.</creator><creator>Bin-Khadem, R.K.</creator><general>Oxford University Press</general><general>Preston</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20010701</creationdate><title>Investigation Into Some Aspects of EMIT d.a.u., TLC, and GC-MS Urinalysis of Bromazepam</title><author>El-Haj, B.M. ; Al-Amri, A.M. ; Hassan, M.H. ; Bin-Khadem, R.K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c424t-6286a1bd67d1729bdb7d26e1e1f5be4658786d8ff012052decaf3dcc9ac02eb93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Analysis</topic><topic>Biological and medical sciences</topic><topic>bromazepam</topic><topic>Bromazepam - analogs &amp; derivatives</topic><topic>Bromazepam - analysis</topic><topic>Bromazepam - metabolism</topic><topic>Bromazepam - urine</topic><topic>Chromatography, Thin Layer</topic><topic>Enzyme Multiplied Immunoassay Technique</topic><topic>Gas Chromatography-Mass Spectrometry</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Substance Abuse Detection - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>El-Haj, B.M.</creatorcontrib><creatorcontrib>Al-Amri, A.M.</creatorcontrib><creatorcontrib>Hassan, M.H.</creatorcontrib><creatorcontrib>Bin-Khadem, R.K.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Journal of analytical toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>El-Haj, B.M.</au><au>Al-Amri, A.M.</au><au>Hassan, M.H.</au><au>Bin-Khadem, R.K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Investigation Into Some Aspects of EMIT d.a.u., TLC, and GC-MS Urinalysis of Bromazepam</atitle><jtitle>Journal of analytical toxicology</jtitle><stitle>Journal of Analytical Toxicology</stitle><addtitle>Journal of Analytical Toxicology</addtitle><date>2001-07-01</date><risdate>2001</risdate><volume>25</volume><issue>5</issue><spage>316</spage><epage>322</epage><pages>316-322</pages><issn>0146-4760</issn><eissn>1945-2403</eissn><coden>JATOD3</coden><abstract>Among the different 1,4-benzodiazepine urinary metabolites, those of bromazepam possess distinctive chemical features that may be used in their selective isolation and detection. The detection of bromazepam metabolites in urine was carried out using EMIT d.a.u., thin-layer chromatography (TLC), and gas chromatography-mass spectrometry (GC-MS). The positive EMIT d.a.u. benzodiazepine assay for bromazepam was found to be due to the 3-hydroxybromazepam (3HOB) metabolite. The detection by TLC and GC-MS was carried out after enzyme or acid hydrolysis of the glucuronide conjugates. Both the 2-amino-3-hydroxy-5-bromobenzoylpyridine (AHBBP) metabolite and the acid hydrolysis product of 3-HOB, 2-amino-5-bromobenzoylpyridine (ABBP), were selectively detected by TLC. The bromazepam metabolites in urine could be both isolated and detected selectively by GC-MS in the presence of the metabolites of other 1,4-benzodiazepines that were sometimes used in combination with bromazepam. Both 3-HOB and AHBBP were detected by GC-MS only after trimethylsilyl (TMS) derivatization and not as the free compounds or the acetyl derivatives. Only ABBP was detected in three forms: ABBP, the TMS derivative, and the acetyl derivative. Evidence has been obtained from the enzyme hydrolysis and the TLC studies for the formation of the glucuronide conjugate of AHBBP at the 3-OH group rather than at the 2-NH2 group. All the results have been validated using reference 3-HOB and AHBBP.</abstract><cop>Niles, IL</cop><pub>Oxford University Press</pub><pmid>11499884</pmid><doi>10.1093/jat/25.5.316</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0146-4760
ispartof Journal of analytical toxicology, 2001-07, Vol.25 (5), p.316-322
issn 0146-4760
1945-2403
language eng
recordid cdi_proquest_miscellaneous_18248039
source Oxford Journals Online; Alma/SFX Local Collection
subjects Analysis
Biological and medical sciences
bromazepam
Bromazepam - analogs & derivatives
Bromazepam - analysis
Bromazepam - metabolism
Bromazepam - urine
Chromatography, Thin Layer
Enzyme Multiplied Immunoassay Technique
Gas Chromatography-Mass Spectrometry
General pharmacology
Humans
Medical sciences
Pharmacology. Drug treatments
Substance Abuse Detection - methods
title Investigation Into Some Aspects of EMIT d.a.u., TLC, and GC-MS Urinalysis of Bromazepam
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T18%3A55%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Investigation%20Into%20Some%20Aspects%20of%20EMIT%20d.a.u.,%20TLC,%20and%20GC-MS%20Urinalysis%20of%20Bromazepam&rft.jtitle=Journal%20of%20analytical%20toxicology&rft.au=El-Haj,%20B.M.&rft.date=2001-07-01&rft.volume=25&rft.issue=5&rft.spage=316&rft.epage=322&rft.pages=316-322&rft.issn=0146-4760&rft.eissn=1945-2403&rft.coden=JATOD3&rft_id=info:doi/10.1093/jat/25.5.316&rft_dat=%3Cproquest_cross%3E18248039%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c424t-6286a1bd67d1729bdb7d26e1e1f5be4658786d8ff012052decaf3dcc9ac02eb93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=18248039&rft_id=info:pmid/11499884&rft_oup_id=10.1093/jat/25.5.316&rfr_iscdi=true